Sign Up Today and Learn More About Bluejay Therapeutics Stock
Invest in or calculate the value of your shares in Bluejay Therapeutics or other pre-IPO companies through EquityZen's platform.
Bluejay Therapeutics Stock (BLTH)
Bluejay Therapeutics is a private biopharmaceutical company focused on the development of cures for infectious diseases.
About Bluejay Therapeutics Stock
Founded
2019
Headquarters
San Francisco, CA, US
Industries
Software, Artificial Intelligence, Financial Services
Bluejay Therapeutics Press Mentions
Stay in the know about the latest news on Bluejay Therapeutics
Unlocking immunity: the power of TLR agonists
labiotech • May 08, 2025
Fusion proteins containing il21 muteins for treating cancer and viral diseases
patents • May 04, 2025
Anti-hbsag antibody for treatment of chronic hepatitis d
patents • May 04, 2025
Indazole pyridone compounds and uses thereof
patents • May 04, 2025
Seven biotechs to watch in the hepatitis B space
labiotech • Apr 23, 2025
Bluejay Therapeutics Management
Leadership team at Bluejay Therapeutics
Chief Scientific Officer
Hassan Javanbakht
Board Member
William Rutter
Join now and verify your accreditation status to gain access to:
- Bluejay Therapeutics Current Valuation
- Bluejay Therapeutics Stock Price
- Bluejay Therapeutics Management
- Available deals in Bluejay Therapeutics and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Bluejay Therapeutics Cap Table and Funding History by Share Class and Liquidity Preferences
- Bluejay Therapeutics Revenue and Financials
- Bluejay Therapeutics Highlights
- Bluejay Therapeutics Business Model
- Bluejay Therapeutics Risk Factors
- Bluejay Therapeutics Research Report from SACRA Research
Trading Bluejay Therapeutics Stock
How to invest in Bluejay Therapeutics stock?
Accredited investors can buy pre-IPO stock in companies like Bluejay Therapeutics through EquityZen funds. These investments are made available by existing Bluejay Therapeutics shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Bluejay Therapeutics stock?
Shareholders can sell their Bluejay Therapeutics stock through EquityZen's private company marketplace. EquityZen's network includes over 380K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 47K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
